Syndax Pharmaceuticals Inc Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Syndax Pharmaceuticals Inc annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Syndax Pharmaceuticals Inc Operating Lease, Payments for the quarter ending February 28, 2021 was $270K.
  • Syndax Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $924K, a 63% increase from 2022.
  • Syndax Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $567K, a 4.23% increase from 2021.
  • Syndax Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $544K, a 8.88% decline from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $924K +$357K +63% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $567K +$23K +4.23% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
2021 $544K -$53K -8.88% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-01
2020 $597K +$31K +5.48% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-12
2019 $566K Jan 1, 2019 Dec 31, 2019 10-K 2020-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.